Search Results 101-110 of 16006 for melatonin receptor agonists
The purpose of this study is to demonstrate proof-of-concept feasibility for Mayo OMNI physiologic monitor correlation with sleep-wake measures obtained from ...
The purpose of this study is to assess the safety and tolerability of escalating doses of MC10029 following lymphodepleting (LD) therapy in subjects with ...
About this study. Can T cell receptor repertoires serve as a biomarker of T cell response to a MUC1 vaccine? Participating Mayo Clinic locations.
Scarisbrick's lab discovered human glioblastoma tumors secrete high levels of serine proteases referred to as kallikreins. Kallikreins are the largest ...
The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...
About this study. This pilot, phase II trial studies how well everolimus and letrozole work in treating patients with hormone receptor positive ovarian, ...
"We have found use of GLP-1 receptor agonists and SGLT2 inhibitors to be safe in the majority of these patients based on retrospective analysis, with ...
Have you ever noticed that you start feeling sleepy at about the same time every night? This is an example of your sleep-wake cycle. Your body moves in a fairly ...
Lutetium Lu 177 dotatate, a peptide receptor radionuclide therapy (PRRT), is a tumor-targeted treatment that uses radiation to induce tumor cell death in ...
A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer · Share · Facebook ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.